logo

TG Therapeutics Inc: A Comprehensive Look at the Stock’s Ups and Downs

TG Therapeutics Inc ‘s stock market performance has been somewhat erratic. The company’s stock reached a 1-year high price of $35.67 on 05/04/23, while the lowest value for the same period was recorded at $6.46 on 10/16/23.

52-week price history of TGTX Stock

A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. TG Therapeutics Inc’s current trading price is -60.81% away from its 52-week high, while its distance from the 52-week low is 116.41%. The stock’s price range during this period has spanned from $6.46 to $35.67. In the Healthcare sector, the TG Therapeutics Inc’s shares surpassed a trading volume of approximately 2.72 million for the day, which was noticeably lower compared to the average daily volume of 9.3.49 million over the past three months.

Market Capitalization and Financial Performance: An In-Depth Look

TG Therapeutics Inc (TGTX) has experienced a quarterly decline of -10.78% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.16B and boasts a workforce of 264 employees.

Making Sense of Trading Volume and Moving Average Data

Based on Barchart.com data, the company’s moving average over the 100-day period was 15.75, with a change in price of +1.49. Similarly, TG Therapeutics Inc recorded 4,410,561 in trading volume during the last 100 days, posting a change of +11.93%.

Examining TGTX’s Debt-to-Equity Ratio: What You Need to Know

The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for TGTX stands at 0.69. Similarly, the long-term debt-to-equity ratio is also 0.68.

TGTX Stock Stochastic Average

Today’s raw stochastic average for TG Therapeutics Inc over the last 50 days is 18.45%.This indicates a decrease from the raw stochastic average of the past 20 days, which was 30.57%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 32.54% and 27.95%, respectively.

TGTX Stock Price Performance Analysis

A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The index has shown a price loss of -18.15% this year. Over the last six months, there has been a weaker performance of 108.97%. The price of TGTX leaped by -10.90% during the last 30 days period. For the last 5-days stocks have improved 1.16%.